Biocat

Presentación Informe Biocat 2017

The presentation of the Biocat Report 2017, the reference study that analyzes the life sciences and healthcare sector in Catalonia from 2009, will take place on December 5th.

tirs

The deadline for proposals is January 3 and those selected will be mentored and get the chance to present their project to investors for guidance and/or funding.

Open Innovation Forum - Núria Martí

Companies and research stakeholders in the healthcare, biotech, medtech, food, chemistry, cosmetics and energy sectors can sign up.

Jobs Listing

The sector’s top place for job offers in Catalonia. The system incorporates RSS technology to get the latest updates.

BioRegion Directory

More than 700 companies and a wide network of research centers and science parks, universities, hospitals and support agencies are the cluster of life sciences in Catalonia.

News

10.12.2018
The 2nd annual Open Innovation Forum is here. This program allows companies to share their innovation challenges and get proposals from research groups and centers. The Open Innovation Forum is divided into six areas of...
10.12.2018
Biocat has presented this December a new edition of the Biocat Report, the benchmark study on the healthcare and life sciences sector in Catalonia. More than 300 professionals from the sector attended the event to...
03.12.2018
CRAASH Barcelona, the acceleration program Biocat launched this year under its Moebio initiative, has been recognized by Diario Médico as one of the best ideas in healthcare of 2018. The initiative was recognized in the...

Upcoming events

24.01.2019
Lloc:

Antiga Fàbrica Estrella Damm · Carrer Rosselló, 515 · Barcelona 

25.02.2019 to 27.02.2019
Lloc:

Fira Montjuïc · Av. Reina Maria Cristina, s/n · Barcelona

REPORT
tirs
29.11.2018

Increasing deal flow of projects ready for investment in the BioRegion: this is the main goal of the Investment Readiness Series, a new initiative from Biocat that periodically connects Catalan research projects with local and international investors.